Item 5.02. Departure of Directors or Certain Officers; Election On March 17, 2026, Wendy Yarno, a member of the Board of Directors (the “ Board”) of Iovance Biotherapeutics, Inc. (the “ Company”), provided notice to the Board that she will retire from the Board and not be standing for re-election at the Company’s annual meeting of stockholders (the “ Annual Meeting”) currently anticipated to be held in June 2026. Ms. Yarno will serve out her current term as a director of the Company until the Annual Meeting. The decision to retire and not stand for re-election is not due to a disagreement between the Company and Ms. Yarno on any matter regarding the Company’s operations, policies, or practices. The Company thanks Ms. Yarno for her service to the Board. SIGNATURES